Pax Financial Group, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Pax Financial Group, LLC

  • $531 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 03, 2021
SELL
$122.97 - $147.0 $332,387 - $397,341
-2,703 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$121.19 - $165.49 $78,167 - $106,741
645 Added 31.34%
2,703 $394,000
Q2 2020

Jul 31, 2020
BUY
$104.21 - $156.44 $214,464 - $321,953
2,058 New
2,058 $305,000

Others Institutions Holding ALNY

# of Institutions
644
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $31.3B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Pax Financial Group, LLC Portfolio

Follow Pax Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pax Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pax Financial Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email